SEARCH

SEARCH BY CITATION

References

  • Boulle A, Van Cutsem G, Hilderbrand K et al. (2010) Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa. AIDS 24, 563572.
  • Brinkhof MW, Egger M, Boulle A et al. (2007) Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries. Clinical Infectious Diseases 45, 15181521.
  • Corbett EL, Blumberg L, Churchyard GJ et al. (1999) Nontuberculous mycobacteria. Defining disease in a prospective cohort of South African miners. American Journal of Respiratory and Critical Care Medicine 160, 1521.
  • Corbett EL, Churchyard GJ, Charalambos S et al. (2002) Morbidity and mortality in South African gold miners: impact of untreated disease due to human immunodeficiency virus. Clinical Infectious Diseases 34, 12511258.
  • Egger M, Ekouevi DK, Williams C et al. (2011) Cohort Profile: The international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa. International Journal of Epidemiology 41, 12561264.
  • Ehrlich RI, Adams S, Baatjies R & Jeebhay MF (2011) Chronic airflow obstruction and respiratory symptoms following tuberculosis: a review of South African studies. Int J Tuberc Lung Dis 15, 886891.
  • Ernst JD (2012) The immunological life cycle of tuberculosis. Nature Reviews Immunology 12, 581591.
  • Fenner L, Forster M, Boulle A et al. (2011) Tuberculosis in HIV programmes in lower-income countries: practices and risk factors. International Journal of Tuberculosis and Lung Disease 15, 620627.
  • Havlir DV & Barnes PF (1999) Tuberculosis in patients with human immunodeficiency virus infection. New England Journal of Medicine 340, 367373.
  • Holmes CB, Losina E, Walensky RP, Yazdanpanah Y & Freedberg KA (2003) Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa. Clinical Infectious Diseases 36, 652662.
  • Jarvis JN, Harrison TS, Corbett EL, Wood R & Lawn SD (2010) Is HIV-associated tuberculosis a risk factor for the development of cryptococcal disease? AIDS 24, 612614.
  • Lancioni CL, Mahan CS, Johnson DF et al. (2011) Effects of antiretroviral therapy on immune function of HIV-infected adults with pulmonary tuberculosis and CD4+ >350 cells/mm3. Journal of Infectious Diseases 203, 9921001.
  • Lawn SD (2004) AIDS in Africa: the impact of coinfections on the pathogenesis of HIV-1 infection. The Journal of Infection 48, 112.
  • Lawn SD, Myer L, Bekker LG & Wood R (2006) Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS 20, 16051612.
  • Lawn SD, Harries AD, Anglaret X, Myer L & Wood R (2008) Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 22, 18971908.
  • Miguez-Burbano MJ, Ashkin D, Rodriguez A et al. (2005) Increased risk of Pneumocystis carinii and community-acquired pneumonia with tobacco use in HIV disease. International Journal of Infectious Diseases 9, 208217.
  • Morris A, Beard CB & Huang L (2002) Update on the epidemiology and transmission of Pneumocystis carinii. Microbes and Infection 4, 95103.
  • Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG & Chiller TM (2009) Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23, 525530.
  • Pasipanodya JG, Miller TL, Vecino M et al. (2007) Pulmonary impairment after tuberculosis. Chest 131, 18171824.
  • Penner C, Roberts D, Kunimoto D, Manfreda J & Long R (1995) Tuberculosis as a primary cause of respiratory failure requiring mechanical ventilation. American Journal of Respiratory and Critical Care Medicine, 151 (3 Pt 1), 867872.
  • Shafer RW & Edlin BR (1996) Tuberculosis in patients infected with human immunodeficiency virus: perspective on the past decade. Clinical Infectious Diseases 22, 683704.
  • Wallis RS, Vjecha M, Amir-Tahmasseb M et al. (1993) Influence of tuberculosis on human immunodeficiency virus (HIV-1): enhanced cytokine expression and elevated beta 2-microglobulin in HIV-1-associated tuberculosis. Journal of Infectious Diseases 167, 4348.
  • van Zyl Smit RN, Pai M, Yew WW et al. (2010) Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD (Perspective). European Respiratory Journal 35, 2733.